Genpact filing takes effect. Genpact stock gains 2.00 percent

Published on 10/08/2026 at 20:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The October 7, 2026 filing details Genpact's Delaware move ahead of its vote. Genpact stock costs EUR 30.64 after EUR 30.04, plus 2.00 percent.

Key points in brief

Genpact's S-4 registration statement became effective on October 7, 2026, supporting its proposed Delaware domestication.
The company registered 180.8 million shares for the transaction, while 167.2 million shares were outstanding on September 30, 2026.
Genpact stock was at EUR 30.64 at Lang & Schwarz on October 8, 2026, up 2.00 percent from EUR 30.04.
Second-quarter 2026 revenue rose 7.1 percent to USD 1.343 billion, with adjusted diluted earnings per share up 13.6 percent.

Genpact, BMG3922B1072, Illustration mit AI erstellt.

Genpact (ISIN BMG3922B1072) was trading at EUR 30.64 at Lang & Schwarz on October 8, 2026 at 8:05 p.m. CEST, up 2.00 percent versus the EUR 30.04 prior close of October 7, 2026. The S-4 registration statement for the proposed Delaware domestication became effective on October 7, 2026, StockTitan reports.

Share count frames the Delaware move

The prospectus covers 180,845,599 shares for issuance connected with the proposed move from Bermuda to Delaware. As of September 30, 2026, 167,227,006 common shares were issued and outstanding, according to StockTitan.

The proposed domestication would preserve the Genpact Limited name and the NYSE ticker G. The board is seeking shareholder approval, while the filing says the transaction is expected to take effect on or around March 1, 2027, subject to the required approvals.

What does the filing mean for shareholders?

The proposed change would keep each shareholder's proportional ownership unchanged because each Bermuda common share would convert into an equivalent Delaware share. The board also says the move could simplify the corporate structure and provide potential cost savings, but shareholder rights would shift from Bermuda law to Delaware law, according to StockTitan.

Three dated milestones and the next dates

On September 18, 2026, Genpact disclosed a USD 683,000 exit package for former CFO Michael Weiner, according to StockTitan. On September 24, 2026, management reported second-quarter revenue of USD 1.343 billion, up 7.1 percent year over year, while adjusted diluted earnings per share increased 13.6 percent to USD 1.00, according to Yahoo Finance. On October 7, 2026, the prospectus became effective and covered 180,845,599 registered shares.

Shareholders are scheduled to vote on the Delaware proposal on November 10, 2026, while the next earnings report is scheduled for November 11, 2026, according to Investing.com.

Revenue growth remains the operating counterweight

The second-quarter revenue increase to USD 1.343 billion contrasts with the 2.00 percent same-day rise in the Lang & Schwarz euro quote. Management also expects at least 7 percent revenue growth and at least 12 percent adjusted diluted earnings per share growth for 2026, according to Yahoo Finance.

Stock trades above its prior close

At Lang & Schwarz, Genpact stock was trading at EUR 30.64 on October 8, 2026 at 8:05 p.m. CEST in the after-hours phase, up 2.00 percent versus EUR 30.04 on October 7, 2026. The primary NYSE quote was USD 34.39 at 2:09 p.m. ET on October 8, 2026, while its 52-week range was USD 26.85 to USD 48.64 and market capitalization was USD 5.8 billion as of that date. The further course of trading is shown by the continuously updated real-time quote of Genpact stock.